
Sunshine Biopharma
Yahoo Finance • 12 days ago
Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies
Nanomolar potency against PLpro with broad-spectrum SARS-CoV-2 variants activity Significant dose-dependent suppression of pulmonary viral replication in vivo Strong oral bioavailability and preferential lung enrichment across multiple spe... Full story
Yahoo Finance • last month
A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
MarketNewsUpdates.com A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where c... Full story
Yahoo Finance • 2 months ago
EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval
Pharmaceutical firm Sunshine Biopharma Inc. (NASDAQ:SBFM) on Tuesday said it received regulatory approval to introduce its 2mg generic Dienogest tablets to the Canadian market. The significant milestone marks the company's strategic expan... Full story
- PLTR
Mentioned:
Yahoo Finance • 5 months ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Quantum Cyber (NASDAQ:QUCY) shares increased by 55.0% to $0.5 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.0 million. SELLAS Life Sciences Gr (NASDAQ:SLS) shares increased by 21.26%... Full story
Yahoo Finance • 5 months ago
Why Nextpower Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Shares of Nextpower Inc(NASDAQ:NXT) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results and raised its FY27 sales guidance. The company announced it will acquire assets of Zig... Full story
Yahoo Finance • 3 years ago
Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market
MONTREAL, May 12, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, today annou... Full story
Yahoo Finance • 3 years ago
Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate Update
MONTREAL, April 05, 2023 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today anno... Full story
Yahoo Finance • 4 years ago
Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in Revenue
MONTREAL, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has comple... Full story